FAM174B and bladder transitional cell carcinoma: Additional analyses in GSE32894, GSE31684, and IMvigor210 cohorts consistently demonstrated negative associations between FAM174B and immunomodulators, effector genes, and checkpoint molecules (Figures S8-S10, a-c), collectively establishing FAM174B as a marker of non-inflamed TME in BLCA.